Cargando…
An Efficient New Route to Dihydropyranobenzimidazole Inhibitors of HCV Replication
A class of dihydropyranobenzimidazole inhibitors was recently discovered that acts against the hepatitis C virus (HCV) in a new way, binding to the IRES-IIa subdomain of the highly conserved 5' untranslated region of the viral RNA and thus preventing the ribosome from initiating translation. Ho...
Autores principales: | Parker, Matthew A., Satkiewicz, Emily, Hermann, Thomas, Bergdahl, B. Mikael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6259416/ https://www.ncbi.nlm.nih.gov/pubmed/21193848 http://dx.doi.org/10.3390/molecules16010281 |
Ejemplares similares
-
Substituted imidazopyridines as potent inhibitors of HCV replication()
por: Vliegen, Inge, et al.
Publicado: (2009) -
Small molecule inhibitors of HCV replication from Pomegranate
por: Reddy, B. Uma, et al.
Publicado: (2014) -
HCV dsRNA-Activated Macrophages Inhibit HCV Replication in Hepatocytes
por: Wang, Yizhong, et al.
Publicado: (2015) -
Silencing HCV Replication in Its Reservoir
por: Youssef, Samar Samir, et al.
Publicado: (2018) -
Autophagy in HCV Replication and Protein Trafficking
por: Chu, Ja Yeon Kim, et al.
Publicado: (2021)